☆ 4.7 Article

Design, synthesis, and biological studies of dual URAT1 inhibitor and FXR agonist based on benzbromarone

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Related references

Note: Only part of the references are listed.

Article Chemistry, Medicinal

Discovery of Novel Bicyclic Imidazolopyridine-Containing Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Improved Efficacy and Favorable Druggability

Tong Zhao et al.

Summary: Lesinurad, a uricosuric agent for the treatment of hyperuricemia associated with gout, was modified through scaffold hopping and molecular hybridization. Compound 23 showed increased serum uric acid-reducing activity and stronger URAT1 inhibition activity compared to lesinurad. It also exhibited favorable safety profiles and pharmacokinetic properties, making it a promising drug candidate for the treatment of hyperuricemia and gout.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Emerging strategies for treating gout

Edward M. Huddleston et al.

Summary: Gout is a common and potentially debilitating disease that requires complex treatment, especially for patients with comorbidities. Understanding the pathophysiology is crucial for drug development and research. New treatment strategies and medications are being proposed for patients with different comorbid conditions.

CURRENT OPINION IN PHARMACOLOGY (2022)

Add to Collection

Article Rheumatology

Treatment advances in gout

Lisa K. Stamp et al.

Summary: The purpose of gout treatment is to alleviate symptoms of flares, prevent flares from recurring by lowering serum urate, and minimize structural joint damage and functional impairment. Despite the availability of multiple effective therapies, suboptimal management and outcomes are often due to under-prescribing of urate-lowering therapy by physicians and poor adherence with prescribed therapy by patients.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2021)

Add to Collection

Review Integrative & Complementary Medicine

Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods

Ying Chen et al.

Summary: The review summarizes the methods for assay of URAT1 inhibition and the progress on the discovery of natural and synthetic URAT1 inhibitors in the past five years.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Loganin Alleviates Gout Inflammation by Suppressing NLRP3 Inflammasome Activation and Mitochondrial Damage

Nuri Choi et al.

Summary: The study found that loganin can prevent gout inflammation by inhibiting the NLRP3 inflammasome and reducing neutrophil recruitment. Additionally, loganin blocks mitochondrial DNA synthesis and inhibits mitochondrial damage, thus preventing the occurrence of gout inflammation.

MOLECULES (2021)

Add to Collection

Review Pharmacology & Pharmacy

A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications

Danni Song et al.

Summary: Hyperuricemia is a common metabolic condition caused by reduced excretion of uric acid. URAT1 inhibitors are considered as an effective class of uricosuric agents for treating hyperuricemia, with ongoing research and development in this field expected to lead to significant advancements.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Pharmacophore modeling and virtual screening studies for discovery of novel farnesoid X receptor (FXR) agonists

Shizhen Zhao et al.

Summary: Compounds F4 and F17 identified through virtual screening showed promising FXR agonistic activity in experiments, suppressing the expression of specific genes and holding potential as novel agonists for treating metabolic diseases.

RSC ADVANCES (2021)

Add to Collection

Review Rheumatology

Therapeutic approaches in the treatment of gout

Michael H. Pillinger et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Design, synthesis and structure-activity relationship studies of novel partial FXR agonists for the treatment of fatty liver

Qianqian Qiu et al.

BIOORGANIC CHEMISTRY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor

Wenqing Cai et al.

MOLECULES (2018)

Add to Collection

Review Geriatrics & Gerontology

Lesinurad: A Review in Hyperuricaemia of Gout

Emma D. Deeks

DRUGS & AGING (2017)

Add to Collection

Article Cell Biology

Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis

Haiping Hao et al.

CELL METABOLISM (2017)

Add to Collection

Article Medicine, Research & Experimental

Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis

Fredrik Nyberg et al.

ADVANCES IN THERAPY (2016)

Add to Collection

Article Multidisciplinary Sciences

Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome

Chul-Su Yang et al.

NATURE COMMUNICATIONS (2015)

Add to Collection

Article Rheumatology

The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study

Emma Smith et al.

ANNALS OF THE RHEUMATIC DISEASES (2014)

Add to Collection

Article Pharmacology & Pharmacy

The pharmacokinetics of oxypurinol in people with gout

Sophie L. Stocker et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)

Add to Collection

Article Biochemistry & Molecular Biology

N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors

Kunal Nepali et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2011)

Add to Collection

Article Chemistry, Medicinal

Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors

Shaojie Wang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)

Add to Collection

Article Medicine, General & Internal

Gout

Pascal Richette et al.

LANCET (2010)

Add to Collection

Article Medicine, General & Internal

Prevalence of the metabolic syndrome in individuals with hyperuricemia

Hyon K. Choi et al.

AMERICAN JOURNAL OF MEDICINE (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.